StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CCSI

Consensus Cloud Solutions, Inc.

CCSI Nasdaq Services-Prepackaged Software EDGAR ↗
$34.69
+0.25 +0.73%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$636M
Revenue (TTM) ⓘ
$355M
Net income (TTM) ⓘ
$94.7M
EPS (TTM) ⓘ
$4.94
P/E ratio ⓘ
7.0
Dividend yield ⓘ
—
Free cash flow ⓘ
$106M
Cash ⓘ
$98.9M
Total assets ⓘ
$697M
Gross margin ⓘ
80.2%
52-week range ⓘ
$20.20 – $41.40

AI briefing

from the latest 10-K, 10-Q and 8-K events

Consensus Cloud Solutions is a SaaS provider of secure information delivery, led by its eFax brand, serving regulated industries and shifting focus to larger Corporate and public sector customers.

What they do

Consensus provides secure digital cloud fax and information exchange services, including data extraction and interoperability solutions. Its main brand, eFax, serves a base of approximately 703,000 customers, with product lines like eFax Corporate, ECFax for public sector, eFax Unite for healthcare, and jSign for e-signatures. The company targets regulated industries such as healthcare, government, financial services, law, and education.

Revenue drivers

  • Corporate Solutions — Larger commercial and public sector customers, generating $222.7M in 2025 (about 64% of total revenue), with 65,000 accounts and a monthly ARPA of $300.03.
  • SoHo (small office/home office) — Online fax services for individuals and small businesses, generating $127.0M in 2025 (about 36% of total revenue), with 638,000 accounts and a monthly ARPA of $15.58.
  • Healthcare-specific products — eFax Unite and related services for healthcare interoperability, part of the Corporate segment, leveraging HL7/FHIR and security certifications like HITRUST and FedRAMP to drive growth in the healthcare vertical.

Recent performance

In Q2 2026, revenue increased 4.1% year-over-year to $91.4 million, driven by a 9.3% rise in Corporate revenue to partially offset a 4.7% decline in SoHo. Net income jumped 31.7% to $27.4 million and diluted EPS rose to $1.43, partly due to an unrealized investment gain. Adjusted EBITDA was $48.3 million (52.9% margin), and free cash flow rose to $25.5 million. Full-year 2025 revenue was $349.7 million with net income of $84.5 million and diluted EPS of $4.35.

Strategy

Management is prioritizing growth in the Corporate and healthcare verticals, capitalizing on security certifications like HITRUST and FedRAMP. They accelerated hiring in Q2 2026 to support future revenue growth objectives. The company is also executing a strategic initiative in the SoHo channel that has led to revenue declines but improved profitability. They increased the stock buyback program to $200 million and repurchased approximately 300,000 shares in Q2 2026.

Risks

  • Dependence on regulated industries — Revenue is concentrated in healthcare and government, making the company sensitive to regulatory changes and budget cycles in these sectors.
  • SoHo revenue decline — The strategic focus on Corporate has resulted in continued declines in SoHo revenue, which fell 4.7% in Q2 2026 and has dropped from $162.9M in 2023 to $127.0M in 2025.
  • High leverage — As of June 30, 2026, the company had long-term debt of $548.2M and only $41.6M in shareholder equity, with debt covenants tied to generating sufficient cash flow.
  • Macro and operational risks — Uncertain economy, global conflicts, interest rates, and potential government shutdowns could weaken customer acquisition and retention, while system failures or security breaches could harm the business.

Outlook

Management reaffirmed full-year 2026 guidance and provided Q3 2026 guidance in the Q2 2026 earnings release. They expect continued growth from Corporate, driven by recent hiring and healthcare momentum, while SoHo declines should moderate. The company targets Adjusted EBITDA margins of 50-55% and remains committed to returning capital through buybacks.

Recent SEC filings

40 most recent
Annual, quarterly & current reports